NRTX-1001

N/A

Report date: 2025/11/29 20:00:12

Base Information

Drug NameNRTX-1001
Drug Alias NameGABA-secreting interneuronsNRTX-1001NTX-001
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Neuronal cell therapyCell and gene therapy > Cell therapy > Source of cells > Stem cells-derived
Mechanisms of ActionCell replacementsGABA receptors agonists
TargetsGABA receptors
Therapy Area/IndicationsEpilepsy, Temporal LobeEpilepsyAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeurona Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCalifornia Institute For Regenerative MedicineNeurona Therapeutics IncAxoltis Pharma
Inactive CompaniesN/A
Active IndicationsEpilepsy, Temporal LobeEpilepsyAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A